Insufficient scRNA-seq data for expression of GALR2 at single-cell level.
Insufficient scRNA-seq data for expression of GALR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 94% | 388.27 | 904 / 966 | 16% | 0.31 | 82 / 527 |
| ureter | 0% | 0 | 0 / 0 | 100% | 17.66 | 1 / 1 |
| esophagus | 68% | 21.13 | 977 / 1445 | 32% | 1.06 | 58 / 183 |
| lung | 75% | 9.01 | 434 / 578 | 18% | 0.74 | 207 / 1155 |
| stomach | 73% | 16.99 | 261 / 359 | 17% | 0.39 | 48 / 286 |
| skin | 87% | 13.46 | 1565 / 1809 | 3% | 0.06 | 12 / 472 |
| spleen | 87% | 14.86 | 210 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 76% | 11.21 | 706 / 929 | 0% | 0 | 0 / 0 |
| bladder | 48% | 3.57 | 10 / 21 | 27% | 1.64 | 138 / 504 |
| pancreas | 63% | 5.06 | 208 / 328 | 10% | 0.40 | 18 / 178 |
| brain | 68% | 9.20 | 1791 / 2642 | 2% | 0.12 | 12 / 705 |
| adrenal gland | 60% | 5.84 | 154 / 258 | 9% | 0.30 | 21 / 230 |
| liver | 62% | 7.12 | 141 / 226 | 4% | 0.14 | 16 / 406 |
| prostate | 62% | 6.24 | 153 / 245 | 1% | 0.01 | 3 / 502 |
| uterus | 30% | 2.79 | 51 / 170 | 32% | 1.13 | 146 / 459 |
| thymus | 46% | 3.09 | 298 / 653 | 16% | 0.31 | 94 / 605 |
| adipose | 58% | 6.44 | 694 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 31% | 2.24 | 55 / 180 | 26% | 1.66 | 111 / 430 |
| kidney | 52% | 5.03 | 46 / 89 | 2% | 0.07 | 16 / 901 |
| breast | 50% | 4.26 | 230 / 459 | 2% | 0.06 | 20 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 0.69 | 12 / 29 |
| blood vessel | 41% | 4.26 | 544 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 31% | 0.69 | 14 / 45 |
| muscle | 30% | 1.96 | 243 / 803 | 0% | 0 | 0 / 0 |
| heart | 27% | 1.75 | 233 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO_0046488 | Biological process | phosphatidylinositol metabolic process |
| GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO_0007611 | Biological process | learning or memory |
| GO_0031175 | Biological process | neuron projection development |
| GO_0007631 | Biological process | feeding behavior |
| GO_0090663 | Biological process | galanin-activated signaling pathway |
| GO_0006936 | Biological process | muscle contraction |
| GO_0043647 | Biological process | inositol phosphate metabolic process |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_1902608 | Biological process | positive regulation of large conductance calcium-activated potassium channel activity |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005929 | Cellular component | cilium |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0042923 | Molecular function | neuropeptide binding |
| GO_0004966 | Molecular function | galanin receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GALR2 |
| Protein name | Galanin receptor type 2 (GAL2-R) (GALR-2) |
| Synonyms | GALNR2 |
| Description | FUNCTION: Receptor for the hormone galanin and GALP. Receptor for the hormone spexin-1 . The activity of this receptor is mediated by G proteins that activate the phospholipase C/protein kinase C pathway (via G(q)) and that inhibit adenylyl cyclase (via G(i)). . |
| Accessions | O43603 ENST00000329003.4 |